Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
EV/Core EBITDA

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 44.7216.898.4210.5617.37

What is the latest EV/Core EBITDA ratio of NEULAND LABORATORIES ?

The latest EV/Core EBITDA ratio of NEULAND LABORATORIES is 44.72 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202544.72
Mar202416.89
Mar20238.42
Mar202210.56
Mar202117.37

How is EV/Core EBITDA of NEULAND LABORATORIES Trending?

Years EV/Core EBITDA % Change
Mar2025 44.72
164.77
Mar2024 16.89
100.59
Mar2023 8.42
-20.27
Mar2022 10.56
-39.21
Mar2021 17.37 -

Other Financial Ratios of NEULAND LABORATORIES


Compare EV/Core EBITDA ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹16,986.2 Cr -3.4% 10.7% 53.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,219.0 Cr 0.4% 1.7% 2% Stock Analytics
DIVIS LABORATORIES ₹175,227.0 Cr -0.3% -3.8% 35.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,643.0 Cr 3.9% 11.8% 20% Stock Analytics
CIPLA ₹125,541.0 Cr 1.5% 3.8% 2% Stock Analytics
DR REDDYS LABORATORIES ₹106,063.0 Cr -0.5% -0.1% -5.1% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-3.4%

10.7%

53.7%

SENSEX

-1.2%

-3%

-0.2%


You may also like the below Video Courses